Characteristics of HER2-Positive Breast Cancer according to HER2 2+/ Low or 3+/High Classification by Immunohistochemistry Assay: Study of 205 Cases Treated in a Single Center-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characteristics of HER2-Positive Breast Cancer according to HER2 2+/ Low or 3+/High Classification by Immunohistochemistry Assay: Study of 205 Cases Treated in a Single Center

Published:2021-06-28 Issue:1 Volume:9 Page:1-9
ISSN:2288-5560
Container-title:Journal of Breast Disease
language:en
Short-container-title:J Breast Dis

Author:

Lee Changhee,Park Inseok,Kim Jungbin,Cho Hyunjin,Yang Keunho,Lee Yujin,Park Kyeongmee,Kim Jiyoung,Shin Youngjoo,Gwak Geumhee

Publisher

Korean Breast Cancer Society

Subject

General Medicine

Link

http://jbd.or.kr/upload/jbd-9-1-1.pdf

Reference28 articles.

1. Advances in Targeting Human Epidermal Growth Factor Receptor-2 Signaling for Cancer Therapy: Fig. 1.

2. Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

3. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

4. Prognostic Significance of Human Epidermal Growth Factor Receptor Positivity for the Development of Brain Metastasis After Newly Diagnosed Breast Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vision Transformers for Breast Cancer Human Epidermal Growth Factor Receptor 2 Expression Staging without Immunohistochemical Staining;The American Journal of Pathology;2023-12

2. Rational Liquid Cooling Systems of Internal Combustion Engines;Advances in Science and Technology Research Journal;2022-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP